Dominic Piscitelli
Patrimonio netto: 575 851 $ in data 31/05/2026
Patrimonio netto: 575 851 $ in data 31/05/2026
Dominic Piscitelli is currently an Independent Director at Celyad Oncology SA since 2020, an Independent Director at Alterome Therapeutics, Inc. since 2024, and Chief Financial Officer at Oric Pharmaceuticals, Inc. since 2019.
Former roles include Chief Financial Officer at AnaptysBio, Inc. from 2017 to 2019, VP-Finance, Strategy & Investor Relations at Medivation LLC (California) from 2012 to 2017, Director-Collaborations & Operations Finance at Astellas Pharmaceuticals SA from 2011 to 2012, and Vice President-Treasury & Management Finance at OSI Pharmaceuticals, Inc. from 2009 to 2011.
Education includes undergraduate and MBAistration degrees from Hofstra University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 68.148 ( 0,07% ) | 575 851 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/09/2019 |
| CELYAD ONCOLOGY SA | Direttore/Membro del Consiglio | 06/05/2020 |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Direttore/Membro del Consiglio | 01/04/2024 |
| Società | Posizione | Fine |
|---|---|---|
| ANAPTYSBIO, INC. | Direttore Finanziario/CFO | 16/08/2019 |
| MEDIVATION INC | Direttore Finanziario/CFO | 01/01/2017 |
Astellas Pharmaceuticals SA | Corporate Officer/Principal | 01/09/2012 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Celyad Oncology SA
Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Astellas Pharmaceuticals SA | |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Alterome Therapeutics, Inc.
Alterome Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for oncology treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale